Reckitt sued over supplies of Gaviscon to NHS
Health Secretary Andrew Lansley, 10 strategic health authorities and 146 primary care trusts are suing Reckitt-Benckiser at the High Court for £89m over its marketing of Gaviscon, which has also resulted in the company receiving a £10.2m fine from the Office of Fair Trading (PJ, 23 October 2010, p460).
It is claimed that Reckitt-Benckiser withdrew NHS packs of Gaviscon Original Liquid from the prescription channel after the product’s patent had expired, meaning that prescriptions had then to be issued for Reckitt’s alternative product, Gaviscon Advance Liquid, which had no competition from generic versions since it was still protected by patent.
A spokeswoman for Reckitt Benckiser said the company “will vigorously defend its position in this case”.
Citation: The Pharmaceutical Journal URI: 11073858
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£33.00Buy now
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£54.00Buy now